Development of a Scorecard to Monitor Progress toward National Cholera Elimination: Its Application in Uganda.
Journal
The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507
Informations de publication
Date de publication:
03 05 2023
03 05 2023
Historique:
received:
03
01
2023
accepted:
01
02
2023
medline:
5
5
2023
pubmed:
11
4
2023
entrez:
10
4
2023
Statut:
epublish
Résumé
In 2017, the Global Task Force for Cholera Control (GTFCC) set a goal to eliminate cholera from ≥ 20 countries and to reduce cholera deaths by 90% by 2030. Many countries have included oral cholera vaccine (OCV) in their cholera control plans. We felt that a simple, user-friendly monitoring tool would be useful to guide national progress toward cholera elimination. We reviewed cholera surveillance data of Uganda from 2015 to 2021 by date and district. We defined a district as having eliminated cholera if cholera was not reported in that district for at least 4 years. We prepared maps to show districts with cholera, districts that had eliminated it, and districts that had eliminated it but then "relapsed." These maps were compared with districts where OCV was used and the hotspot map recommended by the GTFCC. Between 2018 and 2021, OCV was administered in 16 districts previously identified as hotspots. In 2018, cholera was reported during at least one of the four previous years from 36 of the 146 districts of Uganda. This number decreased to 18 districts by 2021. Cholera was deemed "eliminated" from four of these 18 districts but then "relapsed." The cholera elimination scorecard effectively demonstrated national progress toward cholera elimination and identified districts where additional resources are needed to achieve elimination by 2030. Identification of the districts that have eliminated cholera and those that have relapsed will assist the national programs to focus on addressing the factors that result in elimination or relapse of cholera.
Identifiants
pubmed: 37037429
doi: 10.4269/ajtmh.23-0007
pii: tpmd230007
pmc: PMC10160876
doi:
Substances chimiques
Cholera Vaccines
0
Types de publication
Review
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
954-962Subventions
Organisme : World Health Organization
ID : 001
Pays : International
Organisme : NIAID NIH HHS
ID : R01 AI123422
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI175214
Pays : United States
Références
BMJ Open. 2022 Sep 19;12(9):e063703
pubmed: 36123095
Vaccine. 2020 Feb 29;38 Suppl 1:A132-A140
pubmed: 31519444
Emerg Infect Dis. 2021 Nov;27(11):2932-2936
pubmed: 34670655
Lancet Glob Health. 2018 Jun;6(6):e680-e690
pubmed: 29731398
Am J Trop Med Hyg. 2021 Feb 08;104(4):1225-1231
pubmed: 33556038
Trop Med Infect Dis. 2021 May 11;6(2):
pubmed: 34064986
PLoS Negl Trop Dis. 2017 Dec 28;11(12):e0006118
pubmed: 29284003
Int J Infect Dis. 2022 Sep;122:215-221
pubmed: 35605949
Emerg Infect Dis. 2019 May;25(5):856-864
pubmed: 31002075
Vaccine. 2020 Feb 29;38 Suppl 1:A18-A24
pubmed: 31326255
Lancet. 2017 Sep 23;390(10101):1539-1549
pubmed: 28302312
Clin Infect Dis. 2020 Oct 23;71(7):1635-1642
pubmed: 31891368
BMJ Glob Health. 2020 Jun;5(6):
pubmed: 32601092
PLoS One. 2016 Jun 03;11(6):e0156674
pubmed: 27258124
Pan Afr Med J. 2020 Dec 22;37:368
pubmed: 33796181
BMC Med. 2022 May 2;20(1):167
pubmed: 35501853